Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence - Wikidata - wikimedia - TriplyDB

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence

http://www.wikidata.org/entity/Q35589651

about

A summary of the new GINA strategy: a roadmap to asthma control CTNNA3 and SEMA3D: Promising loci for asthma exacerbation identified through multiple genome-wide association studies Predicting asthma exacerbations employing remotely monitored adherence.Living with asthma and chronic obstructive airways disease: Using technology to support self-management - An overview.Differing effects of metformin on glycemic control by race-ethnicity.25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation.Nocturnal asthma and the importance of race/ethnicity and genetic ancestry Inner city asthma.Primary adherence to controller medications for asthma is poor.Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population.Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.Changes in clinical conversations when providers are informed of asthma patients' beliefs about medication use and integrative medical therapies.Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma.Modeling the impact of increased adherence to asthma therapy.Asthma medication adherence: the role of God and other health locus of control factors.A meta-analysis of genome-wide association studies for serum total IgE in diverse study populations A review of the value of innovation in inhalers for COPD and asthma.Comparison of β-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.Examining the relationship between depression and asthma exacerbations in a prospective follow-up study Management of asthma in the elderly patient.Electronic Adherence Monitoring in a High-Utilizing Pediatric Asthma Cohort: A Feasibility Study.Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence Racial disparities in lipid control in patients with diabetes.Protocol for a systematic review to identify and weight the indicators of risk of asthma exacerbations in children aged 5-12 years.The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial.Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects.A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness Genetic Signatures of Asthma Exacerbation.Year in review 2011: asthma, chronic obstructive pulmonary disease and airway biology.Exacerbations of severe asthma.Clinical year in review III: asthma, chronic obstructive pulmonary disease, environmental and occupational lung disease, and ethics and end-of-life care.The misuse of asthma drugs.Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.Inhaled corticosteroids for asthma: on-demand or continuous use.

P2860

Q26799984-EEE2A5ED-92BE-4CC3-857B-619111C4EDB6 Q28396143-F0822A35-AE80-4D6C-B2F7-A1AC7F8E7BD9 Q30360481-956D48DB-F15F-43B8-BC56-DF16A0114374 Q33450151-A2C359A5-E218-48EE-B0A7-C27339A4D75D Q34130997-2B34BE4E-A384-4868-809A-9EECE189EDAD Q34472976-9C24B231-8252-4E20-A65F-66E1B175681C Q34480370-CBDC19D1-82DC-4DA3-AA75-EB85CE884611 Q34625257-1999C05F-E078-4825-8BDF-10275B82122E Q35127886-C5E7A3E9-2459-4397-961C-B9DC8DC20895 Q35676597-3249AB10-A538-47E3-92D8-D21E107B79EC Q35691991-8AD6A093-BB54-44F3-88BA-EF2DD1F1A696 Q35923040-6DF15E23-3B83-495C-ADFB-320B80251E88 Q36225318-E8E2A63A-89CD-4C0B-A0CC-EAA582D2C212 Q36352557-5A62B1DF-3A40-43DC-9997-1CAD67C37D3E Q36404609-90397E76-098B-47DD-8E80-AA3FE9666598 Q36438022-98C0A271-D173-460A-A923-5D4B285D0876 Q36454156-17352D5D-171C-4FAA-8531-1F615A9F2BD5 Q36573582-23CAD5EA-E7D5-4A25-904E-447C7B8D5B90 Q36681270-7803A974-FA23-4468-AAE5-15EC739DC1C3 Q36714639-E2E085D2-D740-43E6-A81E-CABE4DD0C24F Q36918171-A3D84150-ED58-45F7-B771-B3C74B12C053 Q36998508-43520FF3-8B6F-4F75-9DB6-378DF6A20013 Q37027409-3812D18E-4BE5-4739-A10C-0463E9C72172 Q37072493-9ADD28E9-B6AC-48E4-91E5-8BEF0C59C318 Q37137128-D6D6ADDD-AB88-47BC-8586-50A9DB9CAC2D Q37149647-14003D81-23BB-4E1E-8777-5367772103F5 Q37154916-3AC60186-10B3-4233-83FE-BD6BE0EFF05E Q37560263-D2502AA3-3E53-4F30-9448-B8AF73DE5B92 Q37576228-3E6557A3-B0A3-4BD5-BAC4-6704787F23DC Q37603983-BE9D6848-5A01-41B7-9CED-582A513B4C7F Q37610412-53D6B2F9-E9D8-4654-9623-6FD7B386EAE8 Q37647201-94014EC6-A7CA-4054-9AEC-7EAF5EF4C1A3 Q37697471-1B7D3C6C-83E5-4356-9048-53C50A7876FC Q37702899-1FCD0FB2-50E5-4945-BE07-B424D892FA77 Q37976115-33CCB02E-9C7B-40C7-BF47-C0071F47D4C5 Q38003660-55192ABD-FCD8-4655-A075-1F3124C2087B Q38048744-B2165137-DD72-42A6-9219-91F264A83FF4 Q38111795-97AB7821-993A-4106-B213-0D1240204F57 Q38118606-76A0C850-8B10-4B73-8C95-5382876E7A0D Q38154624-1C5AE17E-9AF6-4CAB-844B-284317657A90

P2860

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence

http://www.wikidata.org/entity/Q35589651

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Quantifying the proportion of ...... ed corticosteroid nonadherence

@ast

Quantifying the proportion of ...... ed corticosteroid nonadherence

@en

type

label

Quantifying the proportion of ...... ed corticosteroid nonadherence

@ast

Quantifying the proportion of ...... ed corticosteroid nonadherence

@en

prefLabel

Quantifying the proportion of ...... ed corticosteroid nonadherence

@ast

Quantifying the proportion of ...... ed corticosteroid nonadherence

@en

P1433

Q35589651-8F998B4B-5639-4516-8C1D-84A8658E31BA

P1476

Q35589651-4067E609-30AE-48FB-8740-A7BBDA62F836

P2093

Q35589651-09A09744-F662-4BC6-8525-DA5F35A4D5A5

Q35589651-0ECC9770-1348-42BF-8BAD-21C698AC7F98

Q35589651-1EDC936A-87F0-4529-A667-F09C27F638D8

Q35589651-2D9EA83F-5910-495D-ACAE-DF11985738B7

Q35589651-565FE44C-C59E-4B14-A4B6-54DB03F512E3

Q35589651-8297424A-138B-4B2B-A1F8-56DDDE5899C4

Q35589651-881D5A7E-E105-43B0-8C55-8D0C4B18C6E3

Q35589651-C5D7BA5F-0E1E-495A-A17F-218C0B86D28D

Q35589651-D7C454D3-CE74-445A-A53A-C6DBF176BC56

Q35589651-DFD17776-3504-4241-B5B6-2D41AB4A2B37

P2860

Q35589651-01808AAD-6212-4FCA-A34B-E94F6EDFE9EE

Q35589651-0B490E00-C86D-4A70-A9A1-E121C5D4819D

Q35589651-135199A4-7FB7-471D-9AD7-9531A7779D02

Q35589651-1BF51A60-7E0C-447D-B4B1-68F8D3C6F97A

Q35589651-1C1D374C-66D6-4D55-9FF8-DEF67B6CF2F1

Q35589651-24FC205D-8E46-4374-82B2-00FB4D4EBC2E

Q35589651-301FBB44-F851-4FC4-95E9-1204BA25DA0C

Q35589651-31D61E69-1B80-44BE-8457-CB4C9E380263

Q35589651-335BA896-4F82-451A-9F74-7416833C9816

Q35589651-3C30925E-F9EC-441A-9569-EF5DB3C9F12C

P304

Q35589651-6E6DD3DD-F6CB-47FF-96B1-C4A80735EC25

P31

Q35589651-0A8274C7-2722-4369-981A-1B6191C196DE

P356

Q35589651-1BCDC341-3224-40D1-9578-C51A09D61B8E

P407

Q35589651-52A65C30-C456-4573-B8FC-4B2E8365129C

P433

Q35589651-F8988EC5-0F61-4211-8B0A-AA936085DD68

P478

Q35589651-3E9EAAF2-D97C-40D1-97C0-221E17DCB4C0

P577

Q35589651-2746BDBA-37A9-4B5A-9447-E6D8179779BA

P5875

Q35589651-E2708890-F6E6-47BD-8770-BE6A209092EA

P698

Q35589651-B6B26079-DEDE-44A7-944D-6AB7C1AD8421

P921

Q35589651-60DFE692-C86A-4408-A3B8-325BA15D4A72

P932

Q35589651-DD44CF79-7591-4534-A636-26CFACDAB910

P356

J.JACI.2011.09.011

P1433

The Journal of Allergy and Clinical Immunology

P1476

Quantifying the proportion of ...... ed corticosteroid nonadherence

@en

P2093

Brian K Ahmedani

http://www.w3.org/2001/XMLSchema#string

David E Lanfear

http://www.w3.org/2001/XMLSchema#string

David Favro

http://www.w3.org/2001/XMLSchema#string

Edward L Peterson

http://www.w3.org/2001/XMLSchema#string

Esteban G Burchard

http://www.w3.org/2001/XMLSchema#string

Karen Wells

http://www.w3.org/2001/XMLSchema#string

L Keoki Williams

http://www.w3.org/2001/XMLSchema#string

Manel Pladevall

http://www.w3.org/2001/XMLSchema#string

Rajesh Kumar

http://www.w3.org/2001/XMLSchema#string

Vimal K Chowdhry

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

Standardisation of spirometry

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007

The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma.

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique.

A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma.

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

P304

1185-1191.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2011.09.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51741453

http://www.w3.org/2001/XMLSchema#string

P698

22019090

http://www.w3.org/2001/XMLSchema#string

P921

P932

3229671

http://www.w3.org/2001/XMLSchema#string